Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth.
- DOI
- 10.3389/fimmu.2023.1274199
- Published
- 2023
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2023.1274199,
title = {Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth.},
author = {Alfar R and Napoleon JV and Shahriar I and Finnell R and Walchle C and Johnson A and Low PS},
year = {2023},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2023.1274199},
url = {https://doi.org/10.3389/fimmu.2023.1274199}
}RIS
TY - JOUR TI - Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth. AU - Alfar R AU - Napoleon JV AU - Shahriar I AU - Finnell R AU - Walchle C AU - Johnson A AU - Low PS PY - 2023 JO - Frontiers in immunology DO - 10.3389/fimmu.2023.1274199 UR - https://doi.org/10.3389/fimmu.2023.1274199 ER -
APA
R, A., JV, N., I, S., R, F., C, W., A, J., & PS, L. (2023). Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1274199
Source records
- pubmed · retrieved 2026-09-27T09:56:30.528Z